Search Results for: "Clinic Roundup"
-
Clinic Roundup
Top-line data were reported in July. (See BioWorld Today, July 29, 2010 -
Clinic Roundup
Top-line data showed that PT003 provided superior bronchodilation compared to current market lead Spiriva (tiotropium bromide, Pfizer Inc.), as well as to Foradil (formoterol fumarate, Novartis AG), placebo and the individual components of PT003 (p is less than or equal to 0.0002 for all comparisons -
Clinic Roundup
Neuraltus Pharmaceuticals Inc., of Palo Alto, Calif., reported top-line data from a Phase I trial of NP001, a small-molecule regulator of macrophage activation in development, in 32 patients with amyotrophic lateral sclerosis, showing that the drug was safe and well tolerated when given at four different dose levels as a single dose...Sucampo Pharmaceuticals Inc., of Bethesda, Md., and Abbott, of Abbott Park, Ill., reported positive top-line data from a 48-week Phase III long-term trial of -
Clinic Roundup
Top-line data from TIGER-1 were reported in 2008. (See BioWorld Today, June 9, 2008 -
Clinic Roundup
NuPathe Inc., of Conshohocken, Pa., reported positive top-line data from a 12-month, open-label safety study of Zelrix (transdermal sumatriptan patch) in migraine -
Clinic Roundup
Top-line data from the trial were reported in 2008. (See BioWorld Today, July 29, 2008 -
Clinic Roundup
Top-line data from the randomized studies are expected in the first half of 2012...Seattle Genetics Inc., of Bothell, Wash., said top-line data from a Phase II trial of single-agent brentuximab vedotin (SGN-35) in relapsed/refractory anaplastic large cell lymphoma showed an 86 percent objective response rate -
Clinic Roundup
Zealand and Sanofi reported positive top-line data from the first GETGOAL study in April. (See BioWorld Today, April 16, 2010 -
Clinic Roundup
Enrollment is expected to be completed in the first half of 2011, with top-line data available by the end of next year -
Corrections & Clarifications
An item in BioWorld Today, July 23, 2010, Clinic Roundup should have said that NPS Pharmaceuticals Inc...will report top-line data from its Phase III study of Gattex (teduglutide) early next year -
Clinic Roundup
Top-line data are expected next year and, if positive, should support a new drug application filing -
Clinic Roundup
Top-line data are expected by the end of 2011 -
Clinic Roundup
Top-line data are expected in the third quarter -
Clinic Roundup
Top-line data are expected next quarter -
Clinic Roundup
The company previously reported top-line data from an interim analysis showing that the TRCs were more effective than placebo in a composite efficacy endpoint assessing time to first occurrence of treatment failure, defined as major amputation, all-cause mortality, doubling in wound size and de novo gangrene -
Clinic Roundup
Top-line data are expected about four to six weeks after the last infant is born, which could occur as late as mid-November...A confirmatory safety trial is ongoing, with top-line data expected in the fourth quarter -
Clinic Roundup
Top-line data are expected by the end of this year -
Clinic Roundup
Cytos Biotechnology Ltd., of Zurich, Switzerland, said top-line data from a Phase II study of CYT003-QbG10 in persistent allergic asthma bronchiale showed all patients reported improved outcome parameters vs -
Clinic Roundup
Top-line data from the completed trial are expected in the fourth quarter -
Clinic Roundup
Regado Biosciences Inc., of Basking Ridge, N.J., said initial top-line data from a Phase I study of REG2 showed that the system provided prolonged anticoagulation after a single injection, with rapid reversibility